Clinical Trial Detail

NCT ID NCT02554812
Title A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Pfizer
Indications

urinary bladder cancer

head and neck squamous cell carcinoma

ovarian cancer

Advanced Solid Tumor

melanoma

stomach cancer

triple-receptor negative breast cancer

lung non-small cell carcinoma

Therapies

Avelumab + PF-04518600

Avelumab + PD 0360324

Avelumab + Utomilumab

Avelumab + PF-04518600 + Utomilumab

Age Groups: senior adult

Additional content available in CKB BOOST